CellMax Life
PrivateLast Round
Series C
Mar 23, 2021
Est. Valuation
$14M
Total Funding Raised
$9.76M
Company Overview
CellMax Life is a biotechnology company that develops non-invasive blood tests for early cancer detection and screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellMax Life Comparables
Compare CellMax Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epic Sciences | 81% | |
| Datar Cancer Genetics | 81% | |
| DiaCarta, Inc. | 80% | |
CellMax Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 23, 2021 | ||||
| Grant | Jun 14, 2017 | ||||
| Series A Extension | Jul 26, 2016 |
CellMax Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aflac Ventures | Series C |
| Artiman | Series C, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2016
$9M round led by Artiman
CellMax Life Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellMax Life's valuation, stock price, and market status.